Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | ATM | Q13315 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 4/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 3/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8499459 | 0.90 | ATM (0.81) | MAPTKMT2AATMMEN1L3MBTL1 | |
| SCHEMBL8499460 | 0.90 | ATM (0.81) | MAPTKMT2AATMMEN1L3MBTL1 | |
| SCHEMBL8498780 | 0.89 | ATM (0.83) | MAPTKMT2AATMMEN1L3MBTL1 | |
| SCHEMBL8498782 | 0.89 | ATM (0.83) | MAPTKMT2AATMMEN1L3MBTL1 | |
| SCHEMBL11091843 | 0.85 | PKM (0.54) | MAPTKMT2AATMMEN1L3MBTL1 | |
| SCHEMBL11091845 | 0.85 | PKM (0.54) | MAPTKMT2AATMMEN1L3MBTL1 | |
| SCHEMBL14721806 | 0.82 | TERT (0.49) | MAPTKMT2AATMFAAHRECQL | |
| SCHEMBL14721805 | 0.82 | TERT (0.49) | MAPTKMT2AATMFAAHRECQL | |
| SCHEMBL8499709 | 0.82 | PKM (0.62) | MAPTKMT2AATMMEN1L3MBTL1 | |
| SCHEMBL10717177 | 0.80 | PKM (0.58) | MAPTKMT2AATMMEN1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9345791-B2 | Ligands for targeting of S1P receptors for in vivo imaging and treatment of diseases | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (DE) | 2016-05-24 | — | — | US | disclosed |
| US-20140170067-A1 | NEW LIGANDS FOR TARGETING OF S1P RECEPTORS FOR IN VIVO IMAGING AND TREATMENT OF DISEASES | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (DE) | 2014-06-19 | — | — | US | disclosed |
| WO-2013026765-A1 | NEW LIGANDS FOR TARGETING OF S1P RECEPTORS FOR IN VIVO IMAGING AND TREATMENT OF DISEASES | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (DE) | 2013-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140170067-A1 | NEW LIGANDS FOR TARGETING OF S1P RECEPTORS FOR IN VIVO IMAGING AND TREATMENT OF DISEASES | S1PR1, S1PR5, S1PR2 | MAPT 3493/4885KMT2A 4199/4885ATM 4049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.